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Acute liver failure (ALF) secondary to malignant infiltration of the liver from urothelial carcinoma is a very 
rare clinical condition and is often diagnosed only after death. Upper tract urothelial carcinoma (UTUC) is a 
rare, from 5% to 10% of all urothelial tumours, but possible cause of ALF when there is extensive liver 
metastatic involvement. We report the case of a patient who died in the intensive care unit (ICU) of our 
hospital from multiple organ failure (MOF) secondary to ALF, as a result of infiltration of the liver from 
UTUC diagnosed after surgery. 
PRESENTATION OF THE CASE:  
A 69-year-old Caucasian man was referred to our hospital for hematuria, melena, right upper quadrant 
(RUQ) pain and jaundice developed over the previous two weeks. After multidisciplinary discussion, he 
underwent emergency exploratory laparotomy to perform cholecystectomy because of suspected acute 





From the diagnosis of the renal mass and the death of the patient, a few days have passed, and the 
diagnosis of UTUC has been put only at histological examination.The most common sites of metastases 
from UTUC are lymph nodes, lungs, liver, bones and peritoneum. Moreover, liver metastases have been 
identified to have an independent negative impact on overall survival in a patient affected by UTUC. 
CONCLUSION:  
The authors suggest that this condition should be taken into account when dealing with patients with 
evidence of a renal mass and simultaneous ALF.  
KEYWORDS: Acute liver failure, Upper tract urothelial carcinoma (UTUC), emergency surgery 
 
INTRODUCTION 
Acute liver failure (ALF) secondary to malignant infiltration of the liver from urothelial carcinoma is a very 
rare clinical condition and is often diagnosed only after death[2]. Upper tract urothelial carcinoma (UTUC) is 
a rare, from 5% to 10% of all urothelial tumours [3], but possible cause of ALF when there is extensive liver 
metastatic involvement[4]. Rarely these disease are managed in the emergency setting, because are often 
diagnosed by urologists and the overall survival is about 34 months for the UTUC itself; the most recognized 
risk factors that cause this tumous are cigarette smoking, exposure to chemical solvents, exposure to 
arsenic, the use of phenacethine; there is also a clinical entity, the Balkan endemic nephropathy, which 
determines an interstitial inflammatory damage responsible for 50% of renal tumors in that region.[4]  
We report the case of a patient who died in the intensive care unit (ICU) of our hospital from multiple organ 















rate of systemic metastasis in UTUC with muscle invasion is about 30%[5]. Only a minority of patients with 
this condition present involvement of extra-regional lymph nodes and other distant metastasis at the 
moment of diagnosis[6].  
PRESENTATION OF THE CASE 
A 69-year-old Caucasian man was referred to our hospital for hematuria, melena, right upper quadrant 
(RUQ) pain and jaundice developed over the previous two weeks. In his past medical history, the only 
cholelithiasis was recorded. Physical examination highlighted melena, hemoptysis and tenderness in the 
RUQ. Laboratory tests run in the emergency department revealed a level of hemoglobin of 7g/dl, platelets 
39.000 Migl/mmc, white blood cell 13.99 Migl/mmc (neutrophils 69.9%), PT 1.61, aPTT 3.10, albumin 2.2 
g/dl, total bilirubin 9.23 mg/dl, direct bilirubin 7.53 mg/dl, aspartate aminotransferase (AST) 213 IU/l, and 
alkaline phosphatase 567 IU/l , Creatinine 1.32mg/dl, CRP 5.5 mg/dl.  
CT scan of the chest and the abdomen was performed in the emergency department. Diffuse alveolar 
haemorrhage with right pleural effusion and mediastinal lymphadenopathy was demonstrated. In the 
abdomen, the main finding was a large solid lesion of the left kidney (6.5cm x 6.2cm), with multiple regional 
lymphadenopathies and a homogeneously enlarged liver without evident focal lesions. The gallbladder had 
focal thickening of its walls. Also, the RMI confirmed the presence of a thickened wall of the gallbladder 
with a surrounding thin fluid layer; no signs of hepatic infiltration from solid organ tumour was detected.  
FIG. 1 FIG. 2 
The patient was brought to the ICU and required ventilatory support. It was necessary to transfuse him 
with multiple packed red blood cells, plasma and platelets to revert the hemorrhagic shock he developed 
soon after hospitalisation, due to bleeding from the left kidney’s mass.  He also underwent left renal artery 
embolisation to control the urinary tract bleeding. Since LFTs were out of range, hepatitis A, B, C and E 
serologies were tested in the suspect of acute hepatitis. They all came back negative. The patient had no 
history of alcohol abuse, and there were no signs of hepatotoxic medications intake.  
After multidisciplinary discussion, he underwent emergency exploratory laparotomy to perform 
cholecystectomy because of suspected acute cholecystitis considered as a septic focus within the left 
kidney.  At the time of the laparotomy, the liver appeared yellowish with thin fibrous streaks, no signs of 
acute cholecystitis were observed. However, the cholecystectomy was performed, such as a left 
nephrectomy and a wide liver biopsy. After the surgical procedure, the clinical condition of the patient 
rapidly worsened: he developed atrial fibrillation, acute renal failure and respiratory insufficiency. He 
developed MOF and died on the 6
th
 postoperative day.  
The result of histological exams confirmed multiple spots of high-grade carcinoma in hepatic tissue with an 
immunophenotype compatible with urothelial carcinoma (CK 5/6-; CK20+; CDX2-; PAX8-; TTF1-). A high-
grade urothelial carcinoma (pT3) was detected in the left kidney. Gallbladder showed modest acute on 
chronic inflammation. 
The autopsy revealed a grossly enlarged liver, that was granular in appearance with ‘‘salt and pepper’’ 
distribution of the metastases without any focal lesion. Microscopically there was the near-complete 
parenchymal replacement by metastatic tissue. 
DISCUSSION 
We reported the clinical case of a patient who died in an intensive care unit where he was admitted directly 
from the emergency room in good general conditions but with an initial septic state. From the diagnosis of 
the renal mass and the death of the patient, a few days have passed, and the diagnosis of UTUC has been 
put only at histological examination. The absence of a diagnosis and the septic condition of the patient with 
a radiological doubt of cholecystitis as well as the need to remove the embolized kidney led the 















this; we have found that UTUC is uncommon and accounts for approximately 5% of all urothelial 
malignancies[3,7]. The treatment of choice for patients detected in advanced stage of the disease is the 
combination of cisplatin-based systemic chemotherapy and radical nephroureterectomy [8]. UTUC also had 
a high potential for local and distant recurrence[9]. The most common sites of metastases from UTUC are 
lymph nodes, lungs, liver, bones and peritoneum. Moreover, liver metastases have been identified to have 
an independent negative impact on overall survival in a patient affected by UTUC[10]. Some author had 
described that in elderly patients with poor possibilities of survival, the watchful-waiting approach, without 
surgery, may extend the survival. [11] 
Furthermore liver metastases from UTUC are usually multifocal hypodense lesions. In our case the 
immunophenotype found on liver biopsy specimen evidenced cytokeratin 20 expression associated with 
low expression of cytokeratin 5/6, that is typical for poorly differentiated tumours characterised by high 
invasiveness[12]. In literature, the most frequent cause of ALF caused by metastatic infiltration of cancer is 
another kind of cancer such as small cell lung cancer or neuroendocrine carcinomas and the differential 
diagnosis has to be done mainly with sepsis and paraneoplastic syndromes such as Stauffer syndrome[13]. 
Laboratory findings highlighted several negative prognostic serum markers for high-grade UTUC, such as 
severe anaemia, low levels of albumin and high level of alkaline phosphatase that are described in the 
literature to be related with advanced pathologic T stage, not an organ-confined disease, lymph-vascular 
invasion, and tumour necrosis[14]. 
CONCLUSION 
We have described a very rare case that has involved many specialists in emergency department 
characterised by a challenging clinical condition that had been treated with surgery in an extreme attempt 
to save the patient. With this case report, the authors suggest that this condition should be taken into 
account when dealing with patients with evidence of a renal mass and simultaneous ALF.  
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1. Pre-operative TC that highlight the presence of a thickened wall of the gallbladder 








































• Unusual clinical presentation of acute liver failure from upper urothelial carcinoma (UTUC) 
• Rarely these disease are managed in the emergency setting 
• the authors suggest that this condition should be taken into account when dealing with patients 
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